Engineered albumin helps a therapeutic protein last longer and cross mucosal barriers
Protein-based medicines have transformed the treatment of many diseases, but they often come with a limitation: they must be injected, sometimes repeatedly, because they are rapidly cleared from the bloodstream. For patients who depend on long-term or lifelong treatment, frequent injections place a considerable burden on everyday life.
Read original article on Phys.org - latest science and technology news stories →Related news
-
Machine learning simulations reveal how plastic transforms into hard carbon
Science
Research
United Kingdom
-
Why do people self-harm? The mind-body divide might hold some clues
Health
Mental Health
-
Comets probably didn't seed life on Earth after all, new study suggests
Science
Research
Global
-
Major Southern Hemisphere ocean layer shifts, raising questions about heat and carbon storage
Science
Research
Global
-
DNA analysis identifies root-dwelling fungi as potential keystone species in forest microbial communities
Science
Biology
-
MapInsights helps police trainees learn the territory
Technology
Software Development
United States
-
Digital tools and 3D printing emerge as key themes in circular economy research
Science
Research
Global
-
New election forecast updates predictions every 10 minutes
Politics
Elections
United States